The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Omega Healthcare Investors Inc

NYSE: OHI
Last

(U.S.) $33.53

Today's change-0.45 -1.32%
Updated April 29 1:54 PM EDT. Delayed by at least 15 minutes.
 

Omega Healthcare Investors Inc

NYSE: OHI
Last

(U.S.) $33.53

Today's change-0.45 -1.32%
Updated April 29 1:54 PM EDT. Delayed by at least 15 minutes.

Omega Healthcare Investors Inc crosses below 50-day moving average

Omega Healthcare Investors Inc is lower today, dropping (U.S.)$0.45 or 1.32% to (U.S.)$33.53 and crossing below its 50-day moving average. Over the last five days, shares have lost 2.53% and are down 4.15% for the last year to date. This security has underperformed the S&P 500 by 6.10% during the last year.

Key company metrics

  • Open(U.S.) $33.81
  • Previous close(U.S.) $33.98
  • High(U.S.) $34.00
  • Low(U.S.) $33.47
  • Bid / Ask(U.S.) $33.52 / (U.S.) $33.53
  • YTD % change-4.15%
  • Volume363,548
  • Average volume (10-day)1,241,872
  • Average volume (1-month)1,059,771
  • Average volume (3-month)1,328,067
  • 52-week range(U.S.) $26.96 to (U.S.) $37.70
  • Beta0.81
  • Trailing P/E26.91×
  • P/E 1 year forward17.67×
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend(U.S.) $2.32
  • Dividend yield6.92%
  • Trailing EPS(U.S.) $1.25
Updated April 29 1:54 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+31.38%

Based on its net profit margin of 31.38%, Omega Healthcare Investors Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.28%Sector:HealthcareIndustry:Healthcare Facilities
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2015Q3/2015Q2/2015Q1/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015Mar 31, 201503/31/2015
Revenue211202198133
Total other revenue--------
Total revenue211202198133
Gross profit--------
Total cost of revenue--------
Total operating expense867612347
Selling / general / administrative2010106
Research & development--------
Depreciation / amortization61605931
Interest expense (income), net operating--------
Unusual expense (income)555411
Other operating expenses, total--------
Operating income1251267486
Interest income (expense), net non-operating-41-40-40-34
Gain (loss) on sale of assets0-29--
Other--------
Income before tax64844443
Income after tax64834343
Income tax, total001--
Net income61794143
Total adjustments to net income--------
Net income before extra. items61794143
Minority interest-3-4-2--
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items61794143
Inc. avail. to common incl. extra. items61794143
Diluted net income61794143
Dilution adjustment--000
Diluted weighted average shares198195194135
Diluted EPS excluding extraordinary itemsvalue per share0.310.410.210.32
Dividends per sharevalue per share0.560.550.180.89
Diluted normalized EPSvalue per share0.330.450.440.40